SCHEMBL9853428

SCHEMBL9853428

CSCCc1ccc2c(n1)Oc1ccccc1C(=O)N2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ACVR1 Q04771 2/20 0.35
LRRK2 Q5S007 2/20 0.35
PDGFRA P16234 1/20 0.35
FER P16591 1/20 0.35
LTK P29376 1/20 0.35
CDK8 P49336 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
CSNK1G1 Q9HCP0 1/20 0.34
CYP1A2 P05177 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ROS1 P08922 1/20 0.33
CDK5 Q00535 1/20 0.33
MAPT P10636 6/20 0.32
TDP1 Q9NUW8 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9853425 0.75 KDM4E (0.38) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL4913380 0.74 KDM4E (0.41) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL1366624 0.72 JUN (0.42) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL7336729 0.68 CYP1A2 (0.55) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL16061960 0.68 JUN (0.54) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL380110 0.65 ALOX5 (0.61) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL17975286 0.63 CSNK1G1 (0.56) KDM4EACVR1LRRK2CSNK1G1CYP1A2
SCHEMBL21117454 0.60 MAPT (0.42) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL9853252 0.60 MAPT (0.45) KDM4EACVR1LRRK2PDGFRAFER
SCHEMBL9270079 0.60 CSNK1G1 (0.56) KDM4EACVR1LRRK2CSNK1G1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417534-A1 Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1991-03-20 EP disclosed